PET/MR for Prostate Cancer Restaging: a Phase II Prospective Monocentric Study

NCT05806853 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: 68Ga-PSMA
DRUG: 68Ga-RM2

Sponsor

IRCCS San Raffaele